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Snail is a zinc finger transcription factor that triggers the
epithelial-mesenchymal transition (EMT) by directly
repressing E-cadherin expression. Snail is required for
mesoderm and neural crest formation during embryonic
development and has recently been implicated in the
EMT associated with tumour progression. In a series of
human breast carcinomas, we have analysed the
expression of Snail and that of molecules of the E-
cadherin/catenin complexes. We have also correlated
these data with the pathological features of the tumours.
We show that Snail expression inversely correlates with
the grade of dierentiation of the tumours and that it is
expressed in all the infiltrating ductal carcinomas (IDC)
presenting lymph node metastases that were analysed. In
addition, Snail is expressed in some dedierentiated
tumours with a negative nodal status. Considering that
Snail is involved in the induction of the invasive and
migratory phenotype in epithelial cells, these results
indicate that it is also involved in the progression of
breast ductal tumours, where it could additionally serve
as a marker of the metastatic potential.
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The transcription factor Snail was first described in
Drosophila, where defects in the invagination of the
presumptive mesoderm and of germ band retraction
were seen in mutant embryos (Grau et al., 1984).
Subsequently, Snail homologues were identified in
dierent vertebrates including humans (Hemavathy et
al., 2000; Manzanares et al., 2001). During embryonic
development Snail family members have been impli-
cated in the triggering of epithelial-mesenchymal
transitions (EMT) in the precursors of the mesoderm
and the neural crest, promoting their delamination and
subsequent migration from the primitive streak and the
neural tube, respectively (Nieto et al., 1994; Sefton et
al., 1998; LaBonne and Bronner-Fraser, 2000; Cano et
al., 2000; Carver et al., 2001). In epithelial cells, the
induction of EMT by Snail is mediated by the direct
transcriptional repression of the cell adhesion molecule
E-cadherin. Indeed, Snail has been shown to repress E-
cadherin expression and to trigger EMT associated
with epithelial tumour progression (Cano et al., 2000;
Batlle et al., 2000), the first step in the metastatic
cascade. Very recently, two additional E-cadherin
repressors, SIP1 and E12/E47, have also been described
(Comijn et al., 2001; Pe´rez-Moreno et al., 2001). With
respect to Snail, apart from the inverse correlation
between its expression and that of E-cadherin, a direct
correlation has been observed with the invasive and
metastatic properties of mouse and human tumour cell
lines derived from tissues such as skin, breast, colon,
oral mucosa and melanoma (Batlle et al., 2000; Cano
et al., 2000; Poser et al., 2001; Yokoyama et al., 2001).
Furthermore, Snail is expressed at the invasive front of
skin tumours induced by chemical carcinogenesis in the
mouse (Cano et al., 2000).
The first evidence that Snail is expressed in primary
human tumours was recently presented by Cheng et al.
(2001) who analysed the dierent mechanisms of E-
cadherin inactivation in breast ductal carcinomas. They
identified a correlation between Snail expression and a
reduction or the lack of E-cadherin expression in a
high number of tumours. However, since this study
was carried out by RT–PCR, it was not possible to
perform a direct analysis of the Snail-expressing cells
within the tumour. The high degree of cellular
heterogeneity found in breast cancers and the resulting
variability in gene expression, makes it necessary to
analyse Snail and E-cadherin expression at the cellular
level to directly address the relationship between the
two genes and to assess their association with
clinicopathological features. In addition, RT –PCR
studies can give rise to false positive results since
samples from patients with breast cancer may contain
dierent proportions of tumour cells in relation to
stroma, inflammatory cells and normal tissue and both
Snail and its close family member Slug are expressed in
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fibroblasts (Cano et al., 2000; Batlle et al., 2000). This
expression is not surprising considering that during
embryonic development these genes have been pro-
posed to act as factors implicated in maintaining the
mesenchymal phenotype (Ros et al., 1997).
In order to assess the expression of Snail and E-
cadherin at the cellular level, and in the absence of
specific anti-Snail antibodies, we have carried out non-
radioactive in situ hybridization in tumour sections. We
have combined these data with histological, immuno-
histological and clinicopathological analyses of tu-
mours obtained from 21 patients aged from 35 to 85
and not subjected to chemo- or radiotherapy. Seven-
teen of them corresponded to infiltrating ductal
carcinomas (IDC) and four infiltrating lobular carci-
noma (ILC).
E-cadherin mRNA was detected in normal epithelial
cells (Figure 1c), in all IDCs (17 out of 17, Table 1;
Figure 1f,i) and in two of the four ILCs (Table 1;
Figure 2c). This is in agreement with several
immunohistochemical studies that have reported E-
cadherin expression in normal epithelial cells and
ductal carcinomas, but low or non-detectable expres-
sion in ILCs. Conversely, Snail mRNA was not
detected in normal breast epithelium (Figure 1b) but
it was expressed in a population of stromal fibroblasts
(Figure 2e), confirming the caveats inherent to the
analysis of Snail expression exclusively by RT–PCR.
In the tumors, Snail was expressed in eight of 17 IDCs
(47%; Table 1). Two examples of the IDCs expressing
Snail are shown in Figure 1d – i, where it can be
observed that the areas of Snail expression (Figure
1e,h) correlate with a dedierentiated phenotype
(Figure 1d,g) and loss of E-cadherin transcripts (Figure
1f,i). This is in keeping with previous results where
Snail expression was inversely correlated to E-cadherin
expression in dierent mouse and human cell lines
(Batlle et al., 2000; Cano et al., 2000; Poser et al., 2001;
Yokoyama et al., 2001), and shown to act as a direct
repressor of E-cadherin transcription (Batlle et al.,
2000; Cano et al., 2000). Although not statistically
significant, we observed a higher percentage of tumours
with reduced E-cadherin among the Snail-positive
cancers (Table 2). As has been shown during
embryonic development (Nieto et al., 1994; LaBonne
and Bronner-Fraser, 2000; Carver et al., 2001; Del
Barrio and Nieto, 2002) and in chemically-induced
tumours in the skin of the mouse (Cano et al., 2000),
the onset of Snail activation represents a local
phenomenon associated with EMT and invasiveness.
Therefore, previous immunohistological analyses of a
relatively wide area of the tumour to assess whether E-
cadherin expression is maintained or reduced may be
misleading when later compared to the results of Snail
expression, since a local activation of Snail would not
account for a deficit in E-cadherin in the tumour. In
terms of expression, the inverse relationship between
the two can be only properly analysed by simultaneous
detection of both proteins once specific anti-Snail
antibodies are available, or through the analysis of
adjacent sections as we have performed in our in situ
hybridization studies. In addition, it is worth noting
that E-cadherin expression in breast cancer in vivo
seems to be an unstable process subject to temporary
down-regulation and re-expression, probably under the
control of several regulators (Cheng et al., 2001).
Indeed, previous observations already addressed the
question of the dynamic regulation of E-cadherin
expression in tumours induced in nude mice by
MDCK-ras cells. These invasive tumours showed E-
cadherin downregulation and re-expression in their
large metastases (Mareel et al., 1991). We have also
analysed a few cases with a reduced E-cadherin in the
absence of Snail expression, suggesting that other E-
cadherin repressors may be present. Good candidates
are the recently identified SIP1 and E12/E47 (Comijn
et al., 2001; Pe´rez-Moreno et al., 2001).
In contrast to IDCs, Snail expression was not
observed in any of the four ILCs analysed (Table 1,
Figure 2b). Immunohistochemical studies of breast
cancers have demonstrated that the absence or severe
reduction of E-cadherin expression is a characteristic of
lobular neoplasms, both in situ and infiltrating
(Gamallo et al., 1993; Vos et al., 1997). However, the
expression of E-cadherin at both the protein and
mRNA level in human breast cancer has not been
evaluated. In our sample of ILCs, we observed a good
correlation between these two parameters. In two cases
the absence of E-cadherin was demonstrated by both in
situ hybridization and immunohistochemistry whilst in
the remaining two cases, both E-cadherin mRNA and
protein was observed. Interestingly, in one tumour, the
protein was found at the cell membrane whereas in the
other, it was ectopically located in the cytoplasm
(Figure 2f). These dierent patterns of E-cadherin
expression probably represent dierent mechanisms of
E-cadherin inactivation in the dierent samples.
Molecular studies have shown that in lobular cancer,
inactivation of the E-cadherin gene can occur through
allelic loss, gene mutation, and promoter hypermethy-
lation (Berx et al., 1996; Droufakou et al., 2001).
Mutations have been identified throughout the extra-
cellular domain and at exon-intron boundaries, pre-
dicting the synthesis of dierent truncated proteins
(Berx et al., 1996).
The inability to detect Snail expression in ILCs fits
well with previous observations in vitro where tumour
cell lines with a constitutively inactive E-cadherin gene
were shown not to express detectable levels of Snail.
One example is the bladder transitional-cell carcinoma
T24 cell line (Batlle et al., 2000; Cano et al., 2000) in
which E-cadherin expression is down-regulated as a
result of promoter hypermethylation. This suggests
that in the absence of a functionally active E-cadherin
gene, Snail expression tends to be repressed. However,
this does not seem to be the case in IDCs, since
promoter hypermethylation and Snail expression can
be observed in the same tumour, although it is not
known whether the two mechanisms are operating in
the same cells (Cheng et al., 2001).
We have also analysed the relationships between
Snail expression and that of P-cadherin, b-catenin and
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plakoglobin. Normal breast epithelial cells express E-
cadherin, b-catenin and plakoglobin at the cell
membrane whereas P-cadherin is expressed by myoe-
pithelial cells (Figure 1j). All IDCs expressed E-
cadherin, b-catenin and plakoglobin at the cell
membrane, but expression was reduced in nine
(53%), 11 (65%), and 13 (76%) of the tumours
respectively (Table 1). P-cadherin expression was
detected in six (35%) IDCs. Examples of negative
and positive tumours are shown in Figure 1k and l,
respectively. In poorly dierentiated IDCs, a reduction
in E-cadherin expression is frequently associated with
anomalous P-cadherin expression, suggesting the pre-
sence of common regulatory mechanisms (Palacios et
al., 1995; Gamallo et al., 2001). However, in this study
no correlation between P-cadherin and Snail expression
was observed (P=0.29). Although this could again be
the result of local Snail activation that cannot be
compared with the general levels of P-cadherin
expression, this seems an unlikely explanation since
we have previously reported the absence of a
correlation between Snail and P-cadherin expression
in dierent murine cell lines (Cano et al., 2000).
Moreover, we did not find any relationship between
Snail expression and the expression of b-catenin
(P=0.63), plakoglobin (P=0.62), oestrogen receptors
(P=0.29) or progesterone receptors (P=0.37). Re-
cently, it has been proposed that Snail levels may be
Figure 1 In situ hybridization for Snail (b, e, h) and E-cadherin (c, f, i) and immunohistochemical (IHC) analyses for P-cadherin
(j – l) in normal breast tissue (a – c, j) and invasive ductal carcinomas (d – i, k, l). (a, d and g) show haematoxylin-eosin staining of the
dierent tissues. Snail transcripts are detected in the undierentiated IDCs but are absent from the normal epithelial tissue. An
inverse correlation between E-cadherin and Snail expression is observed. Note the specific expression of P-cadherin in the
myoepithelial cells of the normal tissue (j) and its wide expression in the de-dierentiated IDC shown in (l). A moderately
dierentiated P-cadherin-negative tumour is shown in (k). For in situ hybridization, tumours were gelatin-embedded and 70 mm
vibratome sections were processed as described in Nieto et al. (1996). Serial adjacent sections were used for in situ hybridization for
Snail and E-cadherin, and for haematoxylin-eosin staining after paran-embedding and sectioning (8 mm). The E-cadherin and Snail
probes corresponded to the sequences 3205 to 3735 and 695 to 1297 from the translation initiation codon, respectively. P-cadherin
IHC was carried out as described in the footnote of Table 1. Calibration bars: 50 mm
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regulated by integrin linked kinase (ILK) in colon
cancer cell lines, where ILK seems to activate Snail and
to regulate Tcf-mediated transcription upon the nuclear
translocation of b-catenin (Tan et al., 2001). Although
we can not exclude a role of ILK in the control of
Snail expression in breast cancer, we have not detected
b-catenin nuclear accumulation in any of our tumours,
including those that expressed Snail.
We have performed a statistical analysis to compare
the expression of Snail with the dierentiation grade of
IDCs. Our data support that a relationship exists
between Snail expression and IDC tumour dierentia-
tion. In 47% of these tumours Snail was detected.
Most of the grade 3 tumours and more than a half of
grade 2 tumours expressed Snail, but it was not found
in any of the grade 1 IDCs (Table 2). Indeed, in grade
Table 1 Pathological, in situ hybridization and immunohistochemical results of the complete series
Case Type Grade LNM Snail E-CD E-CD (ISH) P-CD (IHC) b-catenin Plakoglobin ER PR
1 IDC 1 0 7 + + 7 + + + +
2 IDC 1 0 7 + ; 7 ; ; + 7
3 IDC 1 0 7 + + 7 + + + +
4 IDC 1 0 7 + + + + ; + +
5 IDC 2 0 + + ; 7 ; ; + 7
6 IDC 2 0 7 + + + + + 7 7
7 IDC 2 1 + + + 7 ; ; + +
8 IDC 2 0 7 + ; 7 ; ; + +
9 IDC 2 0 7 + + 7 ; ; + +
10 IDC 2 0 + + ; 7 ; ; + +
11 IDC 2 3 + + + 7 + + + +
12 IDC 3 0 + + ; + ; ; 7 7
13 IDC 3 0 7 + ; 7 ; ; + +
14 IDC 3 6 + + ; 7 ; ; + +
15 IDC 3 1 + + + + + ; 7 7
16 IDC 3 1 + + ; + ; ; 7 7
17 IDC 3 0 + + ; + ; ; 7 7
18 ILC 7 4 7 + ;* + ; ; + 7
19 ILC 7 0 7 + ; + ; ; + +
20 ILC 7 0 7 7 7 7 ; ; + 7
21 ILC 7 0 7 7 7 7 ; ; + +
LNM: Lymph node metastases; E-CD: E-cadherin; ISH: in situ hybridization; IHC: Immunohistochemistry; P-CD: P-cadherin; ER: oestrogen
receptor; PR: progesterone receptor. IDC: infiltrating ductal carcinoma. ILC: infiltrating lobular carcinoma; +: postive; 7: negative; ;:
Reduced; *case 18 showed cytoplasmic E-cadherin expression, see Figure 2f. All immunostainings were performed on paran-embedded tissue
sections, using a step of heat-induced antigen retrieval prior to exposure to the primary antibody. Mouse anti-human E-cadherin (clone 4A2c7,
Zymed, San Francisco, CA, USA), P-cadherin, b-catenin, and plakoglobin monoclonal antibodies (Transduction Laboratories, Lexington KY,
USA) were used at a dilution of 1:200, 1:250, 1:1000, and 1:1000 respectively. Membrane expression of E-cadherin, b-catenin, and plakoglobin
was semiquantitatively estimated as maintained (+) or reduced (;) using a composite score obtained by adding the values of the
immunoreaction intensity and the relative abundance of the immunoreactive cells, as previously reported in Gamallo et al. (1993) and Palacios et
al. (1995). A tumour was considered to be P-cadherin (P-CD)-positive when at least 5% of the cells were labelled by P-cadherin antibodies
Figure 2 Snail and E-cadherin expression in invasive lobular carcinomas (a – c, f) and in tumour stroma (d, e). (a and d) show
haematoxylin-eosin stainings. Snail transcripts are absent from the lobular carcinoma which expresses E-cadherin at the mRNA
level (c) and shows cytoplasmic expression of the protein (see the inset in f). Snail expression is also detected in scarce fibroblastic
cells present in the stromal regions (e). Calibration bars: 50 mm
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1 tumours that presented well dierentiated cribiform
in situ components, they were also negative for Snail
expression (Figure 3a – c). In grade 3 IDCs that
expressed Snail, the in situ component also expressed
Snail when it was poorly dierentiated as seen in the
comedo-type one shown in Figure 3d – i. The expres-
sion of Snail in this type of poorly dierentiated in situ
components is in agreement with previous analysis
(Van Diest, 1999) indicating that they lead to
dedierentiated infiltrating ductal carcinomas, whereas
well dierentiated in situ tumours progress to well
dierentiated, tubular, and cribiform infiltrating carci-
nomas. A relationship between Snail expression and
cell dierentiation has also been observed both in vitro
and during early embryonic development (Sefton et al.,
1998; Cano et al., 2000). Well dierentiated cell lines
derived from human breast (MCF7) and colon (HT29P
and LoVo) carcinomas do not express Snail mRNA,
whereas it is expressed in dedierentiated cell lines
from breast (MB435S) and melanoma (A375P) (Cano
et al., 2000; see also Batlle et al., 2000).
In addition to the relationship between Snail
expression and dierentiation, we have found that, in
IDCs, Snail expression correlates with the presence of
lymph node metastases. It was expressed in all the
IDCs with lymph node metastases and all the Snail-
negative tumours were also node negative (Table 2).
This is in agreement with previous results where
ectopic Snail expression in MDCK epithelial cells not
only induced a profound alteration in cell morphology
(spindle cells expressing higher levels of mesenchymal
markers such as vimentin and fibronectin), but also
induced the acquisition of tumorigenic and invasive
properties (Cano et al., 2000). Tumour progression
toward an invasive state which will eventually lead to
the formation of metastases depends on, at least in
part, the active movement of neoplastic cells across the
extracellular matrix. Migration of individual cells or
small groups of cells, as observed in IDCs, requires loss
of cell-cell contact and the acquisition of migratory
properties. In terms of cellular behaviour, this is
reminiscent of the process of EMT. Very probably,
both neoplastic and physiological invasion of tissues by
Table 2 Relationships between Snail expression and pathological
and immunohistochemical features in infiltrating ductal carcinomas
Snail-negative Snail-positive P
Grade
1 4 (100%) 0
2 3 (43%) 4 (57%)
3 1 (17%) 5 (83%) 0.034
Metastases
Negative 8 (67%) 4 (33%)
Positive 0 5 (100%) 0.029
E-cadherin
Preserved 5 (62%) 3 (38%)
Reduced 3 (33%) 6 (67%) 0.347
Fischer’s exact test was used to determine the statistical significance
of the relationships between Snail expression and the pathological
and immunohistochemical variables. The SPSS software package for
Windows (SPSS, Inc., Chicago, IL, USA) was used for the statistical
analysis
Figure 3 Snail and E-cadherin transcripts in in situ components of two IDCs. (a – c) shows a well dierentiated in situ component
depicting high levels of E-cadherin expression and absence of Snail transcripts. (d – i) show a dedierentiated comedo-type in situ
component. Note high levels of Snail expression (h) in areas with disorganized E-cadherin expression (i). Calibration bars: 50 mm
Oncogene
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migrating cells relies upon identical molecular mechan-
isms (Kohn and Liotta, 1995; Locascio and Nieto,
2001). The Snail family of transcription factors are
implicated in triggering EMT in embryonic develop-
ment and a similar role can be proposed for Snail in
IDC tumour progression as previously suggested in
mouse skin chemically-induced carcinomas (Cano et
al., 2000). In this context, it would be interesting to
analyse whether other E-cadherin repressors, such as
E12/E47 and SIP1 (Comijn et al., 2001; Pe´rez-Moreno
et al., 2001) can play a role in maintaining the invasive
phenotype.
Interestingly, Snail is expressed in IDCs with a poor
grade of dierentiation, but that do not present lymph
node metastases (Table 2). Considering the role of
Snail in inducing EMT and invasive properties in
epithelial cells, it is tempting to speculate that Snail
could be a prognostic marker of malignancy in IDCs.
The identification of potentially metastatic tumours is a
long-standing goal for oncologists and would be
extremely useful in the design of more specific
therapies. The loss of E-cadherin expression is
considered as a poor prognostic sign and it has been
correlated with the transition from adenoma to
carcinoma (Perl et al., 1998). Since Snail is a direct
repressor of E-cadherin transcription, the correlation
we have found is very likely to be meaningful. It is
worth noting that although we have not analysed Snail
expression in metastases, we would expect it to be
down-regulated during cell re-attachment, as occurs
during embryonic development once Snail-expressing
migratory cells have reached their destination (Nieto et
al., 1994; Sefton et al., 1998). This would also be in
agreement with the unexpected finding of E-cadherin
re-expression in axillary lymph node metastases
(Bukholm et al., 2000) and in metastases generated in
some experimental systems (Mareel et al., 1991). This
reversibility in gene expression favours mechanisms of
transcriptional regulation and reinforces the idea that
epigenetic mechanisms rather than irreversible genetic
loss may confer upon breast cancer cells a selective
advantage for progression (Cheng et al., 2001).
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